Press release
Personal Care
March 24, 2016

Scientific excellence meets passion – Evonik unveils innovative product solutions and concepts at in-cosmetics 2016 in Paris

One of the global cosmetic industry’s most important annual tradeshows, in-cosmetics, brings together the world’s leading personal care ingredients specialists – including Evonik. True to its approach "The Soul & Science of Beauty," Evonik Personal Care is using the event in Paris to launch several innovations that combine scientific excellence with passion:

Evonik’s Personal Care Business Line will introduce TEGO® SOLVE 55, a naturally based solubilizer for perfume and essential oils as well as TEGO® COSMO C 100, the amino acid derivative creatine that rebuilds and strengthens the hair structure of different types of hair from within. Furthermore, Evonik will present SENSORY KALEIDOSCOPE, a novel tool for formulating skin care products with targeted sensory properties. Another highlight will be the presentation of Evonik’s unique concept Elements of Care, offering high performance formulations to protect the skin and hair from different environmental stress factors.

To underline its expertise in products and concepts for the personal care market, Evonik will give two Innovation Seminars during the show. Julia Sauer will present the novel tool "Sensory Kaleidoscope", and Dr. Christian Hartung will talk about "a natural way to cover different solubilization needs".

But these will not be the only highlights at the Evonik booth. Two other Evonik business lines are using the importance of the in-cosmetics event in April to introduce several innovations: Evonik’s Silica Business Line will introduce a new product for sensory modification in skin care and decorative cosmetic formulations. The new product EXP 9590-1 will be part of the eco-friendly SIPERNAT® PC family. This product group has been specifically designed for the needs of the personal care industry as replacements for microplastics in cosmetic and personal care formulations. Evonik’s Silanes Business Line will present a variety of their Dynasylan® organofunctional silanes which offer valuable effects, such as improved dispersion, when used in cosmetic formulations. Dynasylan® surface-treated inorganic functional pigments and fillers are systematically tailor-made for the targeted application, easily processable and even enable new product forms such as compressed cream powder or water-in-oil emulsion formulations.

As different as these examples are, they share a common approach-combining scientific excellence with a deep sensitivity to the needs and demands of cosmetic manufacturers and consumers. In other words: The Soul & Science of Beauty.

These forward-looking solutions will be showcased at in-cosmetics 2016 in Paris (12-14 April). Come see for yourself – we look forward to welcoming you at our booth K40.

Company information

Evonik, the creative industrial group from Germany, is one of the world leaders in specialty chemicals, operating in the Nutrition & Care, Resource Efficiency and Performance Materials segments. The company benefits from its innovative prowess and integrated technology platforms. In 2015 more than 33,500 employees generated sales of around €13.5 billion and an operating profit (adjusted EBITDA) of about €2.47 billion.

About Nutrition & Care

The Nutrition & Care segment is led by Evonik Nutrition & Care GmbH and contributes to fulfilling basic human needs. That includes applications for everyday consumer goods as well as animal nutrition and health care. This segment employed about 7,000 employees, and generated sales of around
€4.9 billion in 2015.


In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.